NCT06341556 2024-09-04A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell LymphomaFudan UniversityPhase 2 Recruiting52 enrolled
NCT02858258 2017-12-19ASCT After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell LymphomaEuropean Mantle Cell Lymphoma NetworkPhase 3 Recruiting870 enrolled